This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Email citation

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comment

. 2016 Jan;176(1):63-4.

doi: 10.1001/jamainternmed.2015.6068.

Off-label Drug Use and Adverse Drug Events: Turning up the Heat on Off-label Prescribing

Chester B Good¹, Walid F Gellad²

Affiliations

Affiliations

¹ Pharmacy Benefits Management Services, US Department of Veterans Affairs, Hines, Illinois2Division of General Medicine, Department of Medicine, University of Pittsburgh, Pittsburgh, Pennsylvania3Center for Health Equity Research and Promotion, Veterans Af.
² Division of General Medicine, Department of Medicine, University of Pittsburgh, Pittsburgh, Pennsylvania3Center for Health Equity Research and Promotion, Veterans Affairs Pittsburgh Healthcare System, Pittsburgh, Pennsylvania.

PMID: 26524668
DOI: 10.1001/jamainternmed.2015.6068

Comment

Off-label Drug Use and Adverse Drug Events: Turning up the Heat on Off-label Prescribing

Chester B Good et al. JAMA Intern Med. 2016 Jan.

. 2016 Jan;176(1):63-4.

doi: 10.1001/jamainternmed.2015.6068.

Authors

Chester B Good¹, Walid F Gellad²

Affiliations

¹ Pharmacy Benefits Management Services, US Department of Veterans Affairs, Hines, Illinois2Division of General Medicine, Department of Medicine, University of Pittsburgh, Pittsburgh, Pennsylvania3Center for Health Equity Research and Promotion, Veterans Af.
² Division of General Medicine, Department of Medicine, University of Pittsburgh, Pittsburgh, Pennsylvania3Center for Health Equity Research and Promotion, Veterans Affairs Pittsburgh Healthcare System, Pittsburgh, Pennsylvania.

PMID: 26524668
DOI: 10.1001/jamainternmed.2015.6068

No abstract available

PubMed Disclaimer

Comment on

Association of Off-label Drug Use and Adverse Drug Events in an Adult Population.
Eguale T, Buckeridge DL, Verma A, Winslade NE, Benedetti A, Hanley JA, Tamblyn R. Eguale T, et al. JAMA Intern Med. 2016 Jan;176(1):55-63. doi: 10.1001/jamainternmed.2015.6058. JAMA Intern Med. 2016. PMID: 26523731

Similar articles

Off-label drug use is associated with raised risk of adverse events, study finds.
McCarthy M. McCarthy M. BMJ. 2015 Nov 3;351:h5861. doi: 10.1136/bmj.h5861. BMJ. 2015. PMID: 26537616 No abstract available.
Off-label prescribing in pediatric outpatients.
Palmaro A, Bissuel R, Renaud N, Durrieu G, Escourrou B, Oustric S, Montastruc JL, Lapeyre-Mestre M. Palmaro A, et al. Pediatrics. 2015 Jan;135(1):49-58. doi: 10.1542/peds.2014-0764. Epub 2014 Dec 15. Pediatrics. 2015. PMID: 25511119
[Off-label-drug-use: Scientific evidence counts].
Wagner M, El-Armouche A. Wagner M, et al. Dtsch Med Wochenschr. 2016 Mar;141(5):307. doi: 10.1055/s-0042-101364. Epub 2016 Mar 3. Dtsch Med Wochenschr. 2016. PMID: 26939091 German. No abstract available.
Off-Label Use of Ultrasound Contrast Agents for Intravenous Applications in Children: Analysis of the Existing Literature.
Rosado E, Riccabona M. Rosado E, et al. J Ultrasound Med. 2016 Mar;35(3):487-96. doi: 10.7863/ultra.15.02030. Epub 2016 Feb 2. J Ultrasound Med. 2016. PMID: 26839372 Review.
Pediatric Off-Label and Unlicensed Drug Use and Its Implications.
Gore R, Chugh PK, Tripathi CD, Lhamo Y, Gautam S. Gore R, et al. Curr Clin Pharmacol. 2017;12(1):18-25. doi: 10.2174/1574884712666170317161935. Curr Clin Pharmacol. 2017. PMID: 28322168 Review.

See all similar articles

Cited by

Phentermine in the Modern Era of Obesity Pharmacotherapy: Does It Still Have a Role in Treatment?
Lewis KH, Gudzune KA, Ard JD. Lewis KH, et al. Curr Obes Rep. 2024 Mar;13(1):132-140. doi: 10.1007/s13679-023-00546-9. Epub 2024 Jan 3. Curr Obes Rep. 2024. PMID: 38172485 Review.
Off-label Drug Prescription Pattern and Related Adverse Drug Reactions in the Medical Intensive Care Unit.
Raut A, Krishna K, Adake U, Sharma AA, Thomas A, Shah J. Raut A, et al. Indian J Crit Care Med. 2021 Aug;25(8):872-877. doi: 10.5005/jp-journals-10071-23909. Indian J Crit Care Med. 2021. PMID: 34733026 Free PMC article.
Off-label prescriptions in intensive care unit: the Chinese experience.
Liu L, Yang HY, Lou Y, Miao J, Lu XY, Zhao QW, Wang RR, Jiang SP, Zhang XG. Liu L, et al. Ther Clin Risk Manag. 2018 Jan 31;14:195-202. doi: 10.2147/TCRM.S146425. eCollection 2018. Ther Clin Risk Manag. 2018. PMID: 29430181 Free PMC article.
Off-Label Medication Use in the Inpatient Palliative Care Unit.
Kwon JH, Kim MJ, Bruera S, Park M, Bruera E, Hui D. Kwon JH, et al. J Pain Symptom Manage. 2017 Jul;54(1):46-54. doi: 10.1016/j.jpainsymman.2017.03.014. Epub 2017 May 4. J Pain Symptom Manage. 2017. PMID: 28479415 Free PMC article.

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- Ovid Technologies, Inc.
- Silverchair Information Systems
Other Literature Sources
- scite Smart Citations
Medical
- MedlinePlus Health Information